This inventor holds 1 USPTO granted patent and 2 published patent applications. Top assignee: Lexicon Pharmaceuticals, Inc.. Active years: 2025.
Company Filing History:
Years Active: 2025
Title: Xianglu Zeng: Innovator in AAK1 Inhibitor Synthesis
Introduction
Xianglu Zeng is a notable inventor based in Changzhou, China. He has made significant contributions to the field of medicinal chemistry, particularly in the development of compounds that serve as AAK1 inhibitors. His work is characterized by a focus on innovative synthesis methods that have potential therapeutic applications.
Latest Patents
Xianglu Zeng holds a patent for "Methods and compounds useful in the synthesis of an AAK1 inhibitor." This patent details methods for the synthesis of (S)-1-((2',6-bis(difluoromethyl)-[2,4′-bipyridin]-5-yl)oxy)-2,4-dimethylpentan-2-amine and its salts. The compounds described in this patent are valuable for their potential use in treating various diseases.
Career Highlights
Zeng is currently associated with Lexicon Pharmaceuticals, Inc., where he continues to advance his research in pharmacology and drug development. His expertise in synthetic methods has positioned him as a key figure in his field.
Collaborations
Throughout his career, Xianglu Zeng has collaborated with esteemed colleagues, including Tao Chen and Wenxue Wu. These partnerships have fostered a collaborative environment that enhances innovation and research outcomes.
Conclusion
Xianglu Zeng's contributions to the synthesis of AAK1 inhibitors highlight his role as an influential inventor in the pharmaceutical industry. His work not only advances scientific knowledge but also holds promise for future therapeutic developments.